138
Views
48
CrossRef citations to date
0
Altmetric
Original Research

In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration

, , , , , , , & show all
Pages 5395-5404 | Published online: 09 Oct 2012

References

  • SharmaOPAntioxidant activity of curcumin and related compoundsBiochem Pharmacol1976251518111812942483
  • SelvamRSubramanianLGayathriRAngayarkanniNThe antioxidant activity of turmeric (Curcuma longa)J Ethnopharmacol199547259677500637
  • RubyAJKuttanGBabuKDRajasekharanKNKuttanRAnti-tumour and antioxidant activity of natural curcuminoidsCancer Lett199594179837621448
  • MenonVPSudheerARAntioxidant and anti-inflammatory properties of curcuminAdv Exp Med Biol200759510512517569207
  • RaoTSBasuNSiddiquiHHAnti-inflammatory activity of curcumin analoguesIndian J Med Res1982755745787118227
  • NegiPSJayaprakashaGKJaganMohanRaoLSakariahKKAntibacterial activity of turmeric oil: a byproduct from curcumin manufactureJ Agric Food Chem199947104297430010552805
  • Wuthi-udomlertMGrisanapanWLuanratanaOCaichompooWAntifungal activity of Curcuma longa grown in ThailandSoutheast Asian J Trop Med Public Health200031117818211414453
  • ApisariyakulAVanittanakomNBuddhasukhDAntifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae)J Ethnopharmacol19954931631698824742
  • SharmaMManoharlalRPuriNPrasadRAntifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicansBiosci Rep201030639140420017731
  • Lopez-LazaroMAnticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agentMol Nutr Food Res200852Suppl 1S103S12718496811
  • DasLVinayakMAnti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-kappaB signalling in lymphoma-bearing miceBiosci Rep201232216117021831045
  • DevasenaTRajasekaranKNGunasekaranGViswanathanPMenonVPAnticarcinogenic effect of bis-1,7-(2-hydroxyphenyl)- hepta-1,6-diene-3,5-dione a curcumin analog on DMH-induced colon cancer modelPharmacol Res200347213314012543061
  • ParkJConteasCNAnti-carcinogenic properties of curcumin on colorectal cancerWorld J Gastrointest Oncol20102416917621160593
  • ManikandanRThiagarajanRBeulajaSAnti-cataractogenic effect of curcumin and aminoguanidine against selenium-induced oxidative stress in the eye lens of Wistar rat pups: An in vitro study using isolated lensChem Biol Interact2009181220220919481068
  • SongJXSzeSCNgTBAnti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models?J Ethnopharmacol2012139369871122212501
  • MiriyalaSPanchatcharamMRengarajuluPCardioprotective effects of curcuminAdv Exp Med Biol200759535937717569220
  • ThiyagarajanMSharmaSSNeuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in ratsLife Sci200474896998514672754
  • ShankarTNShanthaNVRameshHPMurthyIAMurthyVSToxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs and monkeysIndian J Exp Biol198018173756772551
  • LaoCDRuffinMT4thNormolleDDose escalation of a curcuminoid formulationBMC Complement Altern Med200661016545122
  • AnandPKunnumakkaraABNewmanRAAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm20074680781817999464
  • PanMHHuangTMLinJKBiotransformation of curcumin through reduction and glucuronidation in miceDrug Metab Dispos199927448649410101144
  • SharmaRAStewardWPGescherAJPharmacokinetics and pharmacodynamics of curcuminAdv Exp Med Biol200759545347017569224
  • LuoCFYuanMChenMSPharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administrationInt J Pharm20114101/213814421392565
  • TiyaboonchaiWTungpraditWPlianbangchangPFormulation and characterization of curcuminoids loaded solid lipid nanoparticlesInt J Pharm20073371/229930617287099
  • Gomez-GaeteCFattalESilvaLBesnardMTsapisNDexamethasone acetate encapsulation into Trojan particlesJ Control Release20081281414918374442
  • YangBCChuZFZhuSStudy of pharmacokinetics and tissue distribution of liposomal brucine for dermal administrationInt J Nanomedicine201161109111621698079
  • WangMTJinYYangYXIn vivo biodistribution, antiinflammatory, and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier systemInt J Nanomedicine2010548749720957171
  • MuLFengSSFabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiersJ Control Release200176323925411578739
  • TsaiYMChienCFLinLCTsaiTHCurcumin and its nano-formulation: the kinetics of tissue distribution and blood–brain barrier penetrationInt J Pharm2011416133133821729743
  • PaliwalRRaiSVaidyaBEffect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic deliveryNanomedicine20095218419119095502
  • TiwariRPathakKNanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptakeInt J Pharm20114151/223224321640809
  • des RieuxAFievezVMomtazMHelodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicleassociated epitheliumJ Control Release2007118329430217292503
  • SahuABoraUKasojuNGoswamiPSynthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cellsActa Biomater2008461752176118524701